provide optimum protein folding and hence activity in a very specific lipidic context. Given this complexity, solubilization with a single detergent will never effectively replicate the native lipid environment and hence will always be a suboptimal solution. This issue has been encountered countless times, as even a thermostable protein such as Thermotoga maritima integral membrane pyrophosphatase is stable and active in only a few detergents 11 . Thus many detergent solubilization experiments fail to produce active membrane proteins, and most of these attempts are never published by virtue of the negative nature of the results. The sad consequence is that multiple groups waste valuable time and resources attempting the same experiments without knowing that these experiments have already been proven to be futile.
Attempts to solubilize using detergent also suffer from the lack of a single solution (that is, a single methodology and reagent). This means that experiments to develop a detergent solubilization method for a particular protein are essentially 'open-ended' experiments with an infinite number of combinations of detergents to be tried 11 . The lack of a definitive indication that the project is fruitless also wastes time and resources. Detergent-solubilized membrane proteins are generally inherently unstable with very short 'shelf lives'. This means that comparative experiments between samples often suffer from uncertainty in terms of the specific activity of the preparation. The presence of the detergent itself also often affects downstream experimentation. For example, the interactions between subunits within a membrane protein complex are often perturbed or abolished by the presence of the detergent 12, 13 . In addition, the presence of the detergent disrupts spectroscopic techniques, making it a difficult task to discriminate between the protein and the detergent signal. More recently, scientists have acknowledged the failings of detergents and have begun to develop other moieties aimed at stabilizing membrane proteins. Many of these aim to address one or more of the acknowledged issues with the current approaches. A range of other surface-active agents, including fluorinated detergents 14 , are being trialed; longer polymeric materials (termed amphipols) are also showing some success. These contain a wider range of chemical side chains, providing a higher likelihood that the compound will more effectively replace lipids surrounding a membrane protein 15 .
Overall, detergent solubilization has been the method of choice for the past 40 years, but its significant limitations have placed constraints on the study of membrane proteins. It is possible that new developments will continue to yield success, but there is now a significant effort under way to find an entirely new methodology.
A new approach to membrane protein solubilization
In the late 1990s, several research groups became aware that the continued focus on developing better detergents to extract membrane proteins was not yielding success, and they proposed a new approach. It was reasoned that the common action of detergents to replace lipids from the immediate environment surrounding the protein was not in line with the importance of those lipids to protein structure and function. In fact, a large number of excellent studies of membrane protein folding had for some time pointed to the fact that successful membrane protein folding requires the physically complex membrane structure 8, 16 .
The new approach recognized the importance of the lipid environment that surrounded the membrane protein and proposed a methodological innovation allowing the protein to be extracted along with the surrounding lipid environment: in general, these methods extract between 10 and 100 lipids in close contact with the chosen protein. Early pioneers in this approach were Sligar and coworkers 17 , who showed that amphipathic peptides could be used to stabilize nanoscale disc-like structures that contained a lipid bilayer. This method offered an alternative approach to the stabilization of membrane proteins that allowed biophysical analysis of any protein in the encapsulated bilayer, in a near-tonative protein conformation. Sligar and colleagues also showed some generic applicability in protein stabilization by producing nanoparticles with a range of different membrane proteins, including cytochrome P450 enzymes 18 , the SecYEG channel 19 and the β2-adrenergic receptor 20 . These truly pioneering studies showed that membrane proteins could be isolated complete with an intact lipid bilayer. However, neither approach provides the perfect solution, as both require that the protein be presolubilized in detergent before insertion into the new lipid-containing nanoparticle. In 2009, we published data showing that a simple organic polymer (SMA co-polymer; Fig. 1a ) can be used to directly extract proteins from membranes into SMALPs 21, 22 . This work built on earlier work by Tighe and colleagues 23, 24 on the conformational transitions of SMA and its resultant physical properties. Our work in 2009 provided, perhaps for the first time, a generically applicable method that could extract active membrane proteins without the need for a detergent, whereby the simple observation of the clearing of the cloudy initial solution gave an unambiguous indication of SMALP formation (Fig. 1b) . SMALPs contain a central lipid bilayer supported by an outer annulus of the SMA polymer 25 (Fig. 1c) . The structure is stabilized by the intercalation of the hydrophobic styrene groups between the acyl chains of the bilayer, whereas the hydrophilic maleic acid groups face the solvent . (Fig. 1d) . We have also shown that the encapsulated bilayer retains many of the physical properties of the parent membrane, including the lipid mixture 26 , structural organization and phase behavior 25 . Since the publication of that work, we have worked with a number of collaborators to examine whether the method is widely applicable and whether the resulting preparations are appropriate for analysis using a range of biophysical and biochemical methods. Our work so far has shown that the method can be successfully used to extract proteins with up to 36 transmembrane helices. These studies have included solubilization of AcrB 27 , the ABC transporter PgP 28 , the potassium channel KcsA 29 , the penicillin-binding protein PBP2A 30 and the adenosine A 2A receptor 22 . The method has also been used successfully by Watts and colleagues to purify the seven-transmembrane-protein bacteriorhodopsin 31 alongside the respiratory complex IV (ref. 32) . Importantly, these studies also showed that the extracted proteins maintained activity, with PgP and AcrB displaying greater activity within the SMALP scaffold as compared with detergent isolation. As part of these studies, we have also shown that SMALPencapsulated proteins are amenable to study using a range of techniques, including circular dichroism (CD) 21 , analytical ultracentrifugation (AUC) 21 , differential scanning calorimetry 25 , negative stain 27 and cryo-transmission electron microscopy 28 , and small-angle neutron scattering 25 , demonstrating the general utility of the method. 
Limitations of the SMALP method
The SMALP method detailed in this protocol solves a number of issues that have historically afflicted detergent-based systems. These include the inability to preserve the native membrane context around the protein, diminished sample stability, poor success in solubilization, interference with characterization methods and cost. However, as with any method, there are a number of important factors that have to be considered for the method to be successful. The first is the size of the protein that is being solubilized. The disc-shaped nanoparticle that forms the basis of the method has a nominal maximal diameter that is close to 15 nm, corresponding to a molecular mass of less than ~400 kDa (ref. 25) . This means that proteins that are too large to fit within this limit are unlikely to be successfully solubilized, which eliminates many large membrane protein complexes. In our own studies, we have solubilized more than 30 membrane proteins and have shown that proteins that contain up to 36 transmembrane helical elements can be solubilized. Users should therefore carefully consider whether to attempt the SMALP method if their protein or complex is likely to contain > 36 transmembrane helices. The second important consideration is the pH at which downstream studies of the protein have to be carried out. The SMA polymer forms SMALPs only above pH 6.5 (below this value SMA is not water soluble), which means that experiments with the protein in the SMALP form have to be carried out above pH 6.5 and preferably above pH 7.0. The third limitation is linked to the pH issue, as the SMA polymer is also an effective chelator of divalent cations (e.g., Mg 2 + and Ca 2 + ), with the chelate also being insoluble. This means that experiments that require high concentrations of divalent cations (e.g., above 5 mM) are likely to lead to disruption of the SMALP. This can present issues with membrane proteins that bind nucleotides such as ABC transporters and ATPases. However, the assays for such proteins often use concentrations of nucleotide that are considerably higher than what is required. Often the levels can be safely reduced to preserve the SMALP while maintaining native levels of activity and/or allowing enzyme assays to be performed.
Experimental design
Here we describe a comprehensive set of protocols that are required for preparation of the relevant reagents, use of those reagents to purify membrane proteins in SMALPs and initial biophysical characterization of the resulting preparation. We also describe how to prepare the SMA polymer and SMALPs without encapsulated membrane proteins. We demonstrate how this SMALP protocol has been used to prepare a variety of active proteins from various sources, including bacteria, insect cells, mammalian cells and yeast.
Preparation of styrene maleic acid co-polymer from styrene maleic anhydride co-polymer. The SMA co-polymer reagent used in this method uses a styrene-to-maleic-acid ratio of 2:1. This polymer is currently commercially available only as an anhydride precursor. Styrene maleic anhydride co-polymer with a 3:1 ratio is available commercially, but our studies have shown that discs produced using this material contain bilayers with physical properties that differ from those of the bulk material 25 . Therefore, a protocol is included that allows the 2:1 styrene maleic anhydride co-polymer to be hydrolyzed to produce the maleic acid form.
The starting point of the synthesis is the anhydride form of the polymer, which is available as an inexpensive powder. The anhydride is converted to the acid using a basic hydrolysis protocol.
This protocol describes the production of 25 g of dried SMA 2000 co-polymer. The styrene maleic anhydride co-polymer is dissolved in 1 M NaOH, and the reaction is carried out with heating and refluxing of the solution (Fig. 2a-c) . After the solution has cooled at room temperature (20 °C; Fig. 2d ), the pH is reduced to < 5 by the addition of concentrated HCl to precipitate the SMA co-polymer (Fig. 2e) . To ensure the full precipitation of the polymer, it is important that the pH be monitored at this stage. Preferentially, use pH test strips at this stage rather than a pH meter, as the probe can easily be contaminated with residual polymer. The precipitate is washed three times with water followed by separation using centrifugation. At the end of the third wash, the precipitate is resuspended in 0.6 M NaOH. The solution is precipitated and washed again and finally resuspended in 0.6 M NaOH. The pH is then adjusted to pH 8. As the pH adjustment can lead to polymer precipitation, this step can be a lengthy process. Finally, the polymer is lyophilized using a freeze-dryer. The desiccated SMA copolymer powder can be stored indefinitely at room temperature in a sealed vessel. 25 .
Preparation of SMA lipid particles using co-polymer. We have found that downstream characterization of SMALP-solubilized membrane proteins often requires control samples that contain both lipid and SMA in the form of a protein-free SMALP. For example, in studies of ligand binding, such particles provide a measure of the nonspecific binding of the ligand. In this section, we discuss how to produce a protein-free SMALP. When the SMA co-polymer is added to a lipid suspension, the solution changes from a cloudy solution to a clear one (Fig. 1b) . The SMA interacts with the lipid bilayer, self-assembling into SMALPs (Fig. 1c) .
We have prepared SMALPs from a variety of lipids and relevant mixtures. Here we give a protocol to prepare protein-free SMALPs using E. coli polar lipid extract, which provides a relevant control for experiments using SMALPs containing protein from E. coli membrane. If required, SMALPs containing other types of lipids can be prepared by following the same procedure.
Membrane protein preparations. This protocol outlines the purification of membrane proteins from E. coli membranes, but we have not detailed methods to express membrane proteins, as these methods are independent of the SMALP process. This protocol is intended to be applicable to proteins expressed in many different prokaryotic and eukaryotic systems. The protocol begins with prepared membranes containing the chosen membrane proteins of interest.
Isolation of membrane proteins in SMALPs.
Here we detail the purification of membrane proteins overexpressed in E. coli as an example, but the same protocol can be used in other systems such as insect cells, mammalian cells and yeast. In the example, we show how a SMALP containing a protein with a histidine affinity tag is purified by nickel affinity chromatography. We have applied the same methodology to the purification of recombinant membrane proteins in SMALPs with polyhistidine affinity tags having between six and ten residues at either the N or the C terminus of the protein. As with any protein purification, it is critical to add the affinity tag to a sterically accessible part of the protein to ensure optimum binding of the target to the affinity resin. Therefore, we recommend that affinity tags be inserted distal from the predicted membrane-spanning region. After proteins have been extracted from membranes and encapsulated in SMALPs, they can be purified like any globular protein.
The SMALP is compatible with a variety of buffers. We routinely use a simple solution of either 50 mM Tris and 150 mM NaCl, pH 8.0, or 50 mM potassium or sodium phosphate and 150 mM NaCl, pH 8.0, as a final purification and storage buffer (Tris-buffered or PBS). As a precaution, the choice of buffers to some extent can be dictated by any downstream use of your SMALP protein or the biophysical characterization that is being undertaken. However, as previously stated, buffers should be above pH 7.0 and free of divalent cations (e.g., Mg 2 + and Ca 2 + ), as they interfere with the formation of the SMALP and lead to SMA precipitation.
As a guide to the amount of SMA needed for membrane protein purification, ~1 g of SMA is required for every 10 g of membranes (wet weight). For example, we would calculate the amount of SMA to use by estimating the membrane wet weight: we generally resuspend membranes in between 20 and 40 mg ml − 1 of buffer and add polymer at 2.5% (wt/vol). We have success when we either add powdered polymer directly (described here) to membrane solutions or add a 5% solution to an equal quantity of resuspended membranes. We do not keep the sample on ice at this point, as this reduces membrane fluidity, thus preventing SMA from excising the protein from the lipid environment. This is a significant departure from established methods of membrane protein purification with detergents.
Purification of histidine-tagged proteins encapsulated in SMALPs.
During the development of a chromatographic separation strategy for a SMALP protein, there are a number of parameters that have to be considered. We have found that the most important of these are resin choice and binding regime. When SMALP proteins are to be purified with polyhistidine tags, resin choice can have a substantial effect on protein purification. Of particular importance is the choice of metal bound to the resin (nickel or cobalt). We therefore suggest that an initial small-scale binding trial be carried out to determine which is optimal for the protein being purified. For simplicity, here we have detailed the use of nickel resin for the purification of SMALP proteins with polyhistidine affinity tags. However, we have also had success with cobalt resins: indeed, a case in point would be SMALP AcrB 27 , for which purity and yield were higher when we used cobalt resin rather than nickel. The second optimization choice involves the binding regime used to apply the protein to the resin. Binding of SMALP proteins to resins can be weak and/or slow; thus a slow 'batch' method that allows the SMALP protein to bind overnight or for a minimum of 2 h with gentle mixing at 4 °C may be optimal. In some cases, we observe very tight binding to resins, meaning that a more conventional column-format binding step can be used. We have also found that the relatively high negative charge on the SMALP leads to nonspecific binding to the resin. This can be mitigated by the use of an affinity chromatography buffer that contains at least 500 mM NaCl and in some cases up to 1 M NaCl.
SDS-PAGE analysis and protein concentration estimations.
After chromatographic separations have been carried out, the protein needs to be characterized in terms of purity and amount. Conventionally, SDS-PAGE has served as the main means to assess purity, whereas a number of methods are available to determine the amount of protein. For proteins in SMALPs, SDS-PAGE remains the method of choice, with the only change from working with soluble proteins being the presence of a low-molecularweight 'streak' that stains with Coomassie blue due to the presence of the SMA in the sample. To confirm the identity of proteins, western blotting is recommended, or proteins can be excised from SDS-PAGE acrylamide gels for analysis by mass spectrometry.
Solutions containing free SMA polymer and/or lipid can interfere with traditional protein estimation methods. For example, free polymer has a small but notable absorbance at 280 nm, and therefore interferes with UV detection methods for proteins. Similarly, SMA and lipid can interfere with dye-based assays, including the Bradford assay. However, when free SMA and lipids are removed from solution, for example, by dialysis or size-exclusion chromatography, this problem is reduced. Protein estimates using 280-nm UV detection methods can be performed on purified SMALP proteins when free SMA has been removed, and they provide a reliable estimate of protein concentration.
Initial SMALP-protein characterization. Once the SMALPencapsulated protein has been made, the process of characterization can begin. It is outside the scope of this protocol to describe all the downstream characterization methods that are used for the study of membrane proteins. However, we have found significant utility in performing three analyses with all the proteins that we have produced. CD spectroscopy provides invaluable information on the secondary structure of the protein in the SMALP, allowing a rapid confirmation that the protein is folded within the particle. Ideally, samples should be made up in a buffer containing a low chloride ion concentration ( < 50 mM), the most suitable being a phosphate buffer made using the method of Gomori (after Sørenson) 33 . In these experiments, a demountable cuvette is used to hold the sample. The cuvette has two pieces, comprising two quartz plates, one of which has a sample chamber etched into its surface.
svAUC allows the determination of the size of the SMALP-protein complex and can be used to answer questions related to the oligomerization states of the protein. A quick method of studying the quality of the SMALP protein sample is provided by negative stain microscopy, as exemplified in Postis et al. 27 . This can, in the first instance, give clear indications of global shape, subunit stoichiometry, aggregation and degradation. Subsequent data collection and processing can provide further structural insight to a modest resolution but are outside the scope of this report.
At this stage of the SMALP experiment, it is not necessary to add any further SMA. SMALP protein can be treated like a globular protein and studied in many downstream applications, including characterization using AUC and CD analysis. It is also possible to continue with activity assays and structural studies as you would with a membrane protein that has been purified with a detergent method. EQUIPMENT SETUP Reflux equipment for SMA When preparing to reflux the SMA co-polymer and the 1 M NaOH, rest the round-bottom flask on a cork ring (Fig. 2a) . In a fume hood, position the heating mantle (Fig. 2b) and set up the reflux apparatus with the condenser coil on a retort stand, and attach the apparatus to a water supply (Fig. 2c) . Ensure that the water is flowing through the condenser. CD spectroscopy CD spectra are measured in the far-UV range (190-260 nm) using a JASCO J-715 spectrophotometer and a 1-mm-path-length quartz cuvette containing 0.05 mg ml − 1 of SMALP protein. Collect with a data pitch of 0.5 nm and 16 scans per measurement. In addition, measure the relevant buffer using the same parameters to allow subtraction of the buffer contribution to the spectra. Analytical ultracentrifuge Prepare twin-channel AUC cells with 400 µl of SMALP protein at a concentration between 0.1 and 0.5 mg ml − 1 in one channel and 420 µl of relevant buffer blank in the second channel. Load the cells into the An50Ti rotor in a Beckman Coulter XL-I analytical ultracentrifuge (Beckman 693 Coulter), and operate the centrifuge at 129,000g and at a temperature of 20 °C until the sample has fully sedimented. The protein within the cell is monitored by absorbance at 280 nm. Analyze the data with the program SEDFIT 35 , using the c(S) and c(M) routines to provide estimations of the sedimentation coefficient and mass of the particle. Parameters for SMALP protein partial specific volume, solvent density and viscosity should be calculated using SEDNTERP. Electron microscopy For negative stain microscopy, a modest electron microscope setup can be used, such as an FEI T12 operating at 120 kV accelerating voltage. The negative stain limits the resolution to > ~12 Å, so it is best to optimize the field of view working at ~4 Å per pixel, resulting in a magnification of ~35,000 times based on a GATAN charge-coupled device (CCD) camera. Low-dose mode is not required for the initial screening of grids but is recommended for data collection. The following steps must be carried out in the fume hood. Ensure that the fume hood is working and that the shutter is down. The equipment and protocol described here are for the production of 25 g of SMA co-polymer. 1| Heating with reflux. In the fume hood, weigh 25 g of SMA co-polymer in a weighing boat and transfer it to a 500-ml round-bottom flask.  crItIcal step Ensure that the round-bottom flasks are completely intact and free of any flaws or 'starburst' cracks. Do not use the flasks if these are present.
MaterIals

REAGENTS
2| Using a glass measuring cylinder, add 250 ml of 1 M NaOH to the round-bottom flask (Fig. 2a) .
3| Weigh out 0.5 g of antibumping granules and add to the round-bottom flask. Place the round-bottom flask on the heating mantle with the condenser coil attached (Fig. 2b) . Ensure that the condenser is connected to the water supply and that there is water flowing through (Fig. 2c) . Apply heat and allow the SMA co-polymer suspension in NaOH to gently reach the boiling point. Once the solution is boiling, turn down the heat level and allow the solution to maintain a steady boil, continuing to reflux for 2 h.  crItIcal step Do not omit antibumping granules. It is very important that these are present during reflux, as they prevent violent surges of the solution during reflux.
? trouBlesHootInG
4|
Allow the refluxed solution to cool down to room temperature, with the condenser still connected and water flowing through (Fig. 2d) .  crItIcal step The polymer needs to cool to room temperature before you proceed to the next step.  pause poInt The solution can be stored at 4 o C at this point for up to 4 d.
5|
Polymer precipitation and washing. Check the volume of the refluxed polymer (it will be ~270 ml), and divide it into two equal aliquots in 500-ml centrifuge bottles. Do not transfer more than 150 ml of starter volume of polymer into a 500-ml bottle. The suggested volume is 135 ml.  crItIcal step Use polypropylene centrifuge bottles because of the corrosive nature of the solutions.
6|
Using a 10-ml graduated pipette, gradually add concentrated HCl to the polymer. Start by adding 10 ml to each bottle and mix well. The polymer will start to precipitate (Fig 2e) .
7|
Continue to add HCl until the pH of the solution surrounding the precipitate is < 5. Periodically test the pH of the solution using a pH indicator strip.
8|
To the precipitated polymer, add MilliQ water and fill the centrifuge bottles to the maximum permitted volume (~250 ml). Balance the bottles by adding more water if necessary. ! cautIon Do not overfill the centrifuge bottles.
9|
Centrifuge the polymer suspensions at 11,000g at RT for 15 min.
10|
Carefully pour off the remaining supernatant without disturbing the pellet and thoroughly resuspend the polymer in MilliQ water at a volume close to the maximum permitted volume (~250 ml) per 135 ml of refluxed polymer.
11|
Mix well by vigorous shaking to completely resuspend the precipitate. Balance the bottles by adding more water if necessary. ! cautIon Do not overfill the centrifuge bottles.
12|
13|
Repeat Steps 10-12 two more times.
14|
Carefully pour off the supernatant without disturbing the precipitate. 15| SMA co-polymer second precipitation and wash cycle. Leave the pellets in the centrifuge bottles and add 125 ml of 0.6 M NaOH per bottle. Place the bottle either on a magnetic stirrer or in an orbital shaker at 37 °C at 180 r.p.m. until the pellet has completely dissolved.  pause poInt The solution can be left overnight at 37 °C to dissolve.
16| Repeat Steps 6-14.
17| SMA co-polymer solubilization in 0.6 M NaOH. Once the polymer has re-dissolved in 0.6 M NaOH, check the pH using a pH meter and adjust the pH to ~8.0 using concentrated HCl or NaOH.  crItIcal step Add only a few drops of NaOH at a time, as localized precipitation will occur. Allow the polymer to completely redissolve before adding more drops.  pause poInt Polymer can be stored in the freezer at − 20 °C for up to 6 months before freeze-drying.
18| Freeze-drying the SMA co-polymer:
Transfer the solution to a clean 1-liter round-bottom flask and freeze it at − 20 °C. This usually takes at least 18 h.  crItIcal step Check for imperfections or starbursts in the glass, and ensure that the polymer is thoroughly frozen before proceeding to freeze-drying.
19|
Cover the flask with poly-net, then place the flask of frozen polymer in the freeze dryer according to the manufacturer's instructions and allow the polymer to dry to a powder.
20|
Store the dried polymer at room temperature in a sealed vessel. ! cautIon Although unlikely, the bottle may crack or split during the freeze-drying process. As a precaution, before placing the flask in the freezer, wrap the flask in sealing film.  pause poInt Dried polymer can be stored at room temperature in a sealed container for up to 12 months. part 2: preparation of protein-free lipid nanoparticles using sMa co-polymer • tIMInG ~1 to 2 h ! cautIon Wear gloves and a laboratory coat. This step should be carried out in the fume hood, as chloroform is toxic. 21| Transfer 20 mg of E. coli polar lipid extract (which is supplied in a chloroform solution) to a round-bottomed glass test tube. The concentration of lipid in the extract should be provided by the supplier. Dry the lipid to a thin film under a gentle nitrogen gas flow.  crItIcal step As polymers can leach from plastic in the presence of chloroform, use glass tubes and pipettes for this step.
22|
Remove residual traces of chloroform by drying the pellet under continuous vacuum in a desiccator for 30 min.  crItIcal step It is important to remove all the chloroform from the lipid.  pause poInt The pellet can be left to dry overnight.
23|
Rehydrate the lipids with 1 ml of lipid nanodisc buffer A or B, depending on the downstream application, to form a homogeneous suspension. (For example, buffer B, which uses a phosphate buffer, is appropriate for CD experiments.) Use the same buffer throughout. The addition of 3-mm glass beads and vortexing will help the lipid resuspension. It may be necessary to warm the mixture to 50 °C to obtain complete resuspension.
24|
Sonicate the mixture in a bath sonicator until a translucent milky-white suspension of small unilamellar vesicles has been generated.  crItIcal step When preparing lipid discs, the bath temperature should be above the phase transition temperature of the lipid being used. In the case of E. coli polar lipid extract, this is ~3 °C.
25|
Prepare 5% (wt/vol) SMA solution from the powder produced in Step 20 (choose buffer A or B, as dictated by the downstream application). Gradually add 1 ml of 5% (wt/vol) SMA solution at a temperature above the phase transition temperature of the lipid. During the addition of polymer to the E. coli polar lipid suspension, the milky suspension will become a clear solution (Fig. 1b) .  pause poInt Protein-free SMALPs can be stored at 4 °C for up to 2 weeks. part 3: isolation of sMalp membrane proteins • tIMInG 2 d 26| Membrane solubilization. Isolate membranes from E. coli by following steps 1-5 described in Fotiadis et al. 36 .
If using a different host organism, follow one of the previously described methods for isolating membranes from heterologously expressed proteins for Saccharomycetes cerevisiae cells 37 , Pichia pastoris cells 38 , human embryonic kidney (HEK293) cells, Chinese hamster ovary (CHO) cells or A431 cells [39] [40] [41] , and for baculovirus expression in Insect High Five (Trichoplusia ni) and Sf9 cells 42 . Measure the total mass of the membrane requiring solubilization. As a guide, 10 g of E. coli cell pellet generally yields 1-1.5 g of membrane.
27| On ice, transfer the membranes to a hand homogenizer cooled in an ice bucket. Resuspend the membranes to a final concentration of 40 mg ml − 1 in either SMA solubilization buffer A (Tris) or B (phosphate). Use the same buffer throughout. Homogenize the membranes until they are fully resuspended, ensuring that there are no lumps. When the membranes are fully in solution, the suspension will look turbid.
28|
Weigh out sufficient SMA co-polymer from Step 20, and add this to the suspension to give a final concentration of 2.5% (wt/vol; Fig. 3, left) . Allow the polymer to dissolve by gentle inversion of the tube (Fig. 3, middle) . As the SMA polymer solubilizes the membranes, the suspension should become less opaque (Fig. 3, right) . Alternatively, add the SMA predissolved in the SMA solubilization buffer from Step 25 (5% (wt/vol)) and add the solution at a 1:1 (vol/vol) ratio to the membranes resuspended at 80 mg ml − 1 .
29| Allow the sample to incubate at room temperature for 2 h with gentle agitation.
? trouBlesHootInG  pause poInt The suspension can then be left overnight at 4 °C if required.
30|
Remove the insoluble fraction by centrifugation at 100,000g at 4 °C for 45 min.
31|
Immobilized metal affinity chromatography (IMAC) agarose beads can be prepared during the centrifugation step. Transfer 1 ml of washed IMAC agarose beads into a 50-ml centrifuge tube, according to the manufacturer's instructions. One milliliter of bed volume of resin should be sufficient to purify protein solubilized from 1 g of purified membranes. In cases in which protein expression levels are high, the amount of beads may need to be increased. The resulting protein is then equilibrated in SMA solubilization buffer A or B.
32|
Transfer the supernatant to the prewashed IMAC resin and incubate it overnight at 4 °C with gentle agitation, using a rotary mixer. ! cautIon Do not agitate to the extent that froth forms.
33|
Decant the resin into an empty gravity flow column and collect the flow-through for analysis by SDS-PAGE.
34|
Wash the resin with 10 column volumes of SMA solubilization buffer A or B. Collect the wash for analysis by SDS-PAGE.
35|
Elute the SMALPs with 10 column volumes of SMALP elution buffer in 1-ml fractions.  pause poInt Fractions can be stored at 4 °C safely for up to a week.
part 4: purification of sMalp proteins and estimation of concentration • tIMInG 9-13 h 36| Identify the location and purity of the protein in each sample using established SDS-PAGE methods. To do this, prepare samples from Steps 34 and 35 by adding NuPAGE LDS sample buffer and NuPAGE reducing agent according to the manufacturer's instructions.
37|
Prepare the XCell Surelock mini-cell and fill it with 1× SDS running buffer. 41| Destain the gel with ddH 2 O with gentle shaking at room temperature for 2-5 h; change the ddH 2 O a few times during destaining to aid the development of the stain.
42|
Identify the SMALP protein bands on the gel with reference to the molecular marker. The SMA polymer will be identifiable as a diffuse band at ~8 kDa. In the solubilization fraction this will dominate the signal because of the high concentration of SMA in the sample.
43| Select fractions from
Step 34, and remove imidazole and SMA from the samples containing SMALP protein by dialysis or by using a Vivaspin concentrator. For the former, prepare dialysis tubing in accordance with the manufacturer's instructions and dialyze against 1 liter of size-exclusion chromatography buffer A or B overnight at 4 °C. Change the buffer during this time to ensure the complete exchange of buffer. For the latter, concentrate using a Vivaspin concentrator and then add size-exclusion chromatography buffer A or B. Repeat this process three times to ensure that residual imidazole has been diluted. Once the imidazole has been removed, the SMALP-encapsulated protein can undergo size-exclusion chromatography using a suitable column and fast protein liquid chromatography system (e.g., Superdex 200 Increase 10/300 and ÄKTA purification system) in accordance with the manufacturer's instructions. The resulting fractions can be analyzed using the methods described in Steps 36-42.
44|
Determine the concentration of your SMALP protein using a BCA protein assay kit. Prepare a set of protein standards with a range of concentrations between 25 µg and 2,000 µg ml − 1 by diluting the contents of one albumin standard (bovine serum albumin) ampule into several clean tubes, using the same buffer as for the SMALP protein sample(s). 48| Analyze the data with the continuous c(S) analysis method to determine sedimentation coefficients and molecular masses using the SEDFIT software and the method of Schuck 35 .
49| Protein folding and secondary structure determination using CD spectroscopy. Prepare the SMALP protein sample at a concentration of 0.05 mg ml − 1 , determined in Step 45, and transfer it to a 1-mm cuvette.
50|
Prepare 150 µl of both the SMALP sample and a buffer blank and equilibrate at room temperature.
51| Separate the two quartz plates and pipette 60 µl of buffer into the sample chamber.
52|
Place the second quartz plate on top of the sample.
53|
Using Kimwipe tissue, dry any sample that leaks from the cuvette. 54| Place the sample in the CD spectropolarimeter, close the lid and allow the machine to purge for 3 min.
55|
Record the CD spectrum using parameters that suit the purpose of the experiment. A discussion of how parameters may be optimized can be found in Nordén et al. 43 .
56|
Remove the cuvette and clean it with three washes of MilliQ water followed by ethanol, and dry it in a flow of dry nitrogen.
57|
Repeat Steps 51-56 for the SMALP sample.
58|
Subtract the spectrum for the buffer from the spectrum obtained for the SMALP sample.  crItIcal step Samples should be made up in a buffer containing a low chloride ion concentration (< 50 mM).
59|
Transmission electron microscopy negative stain analysis. Take pre-carbon-coated grids, which can be made manually 44 or purchased directly, for example, from Agar Scientific (AGS160), and charge them. This can be achieved through 40 s of glow discharge; we typically use a Cressington glow discharge unit or place the grids under a UV lamp for 40 min.
60|
Using fine-point tweezers, hold the grid at the edge, being careful not to damage the carbon, and apply 3 µl of purified protein from Step 43 at ~10 µg ml − 1 concentration to the carbon-coated side. Leave it for 30 s.
61|
Remove the excess liquid using filter paper, and apply an additional 3 µl of 1% (wt/vol) uranyl acetate solution. Leave it for 1 min.
62| Repeat
Step 61.
63|
Remove excess liquid and air-dry the grid.  crItIcal step Air-drying the grids under a desktop lamp can produce a more consistent stain depth.  pause poInt The grid can now be stored until required for transmission electron microscopy analysis.
64|
Observe the grids using a suitable electron microscope. Detailed protocols for grid preparation, data collection and processing are beyond the scope of this article; however, we would like to make the reader aware of the following research papers, which provide more in-depth protocols and advice: negative stain grid preparation and initial data collection 45 , cryo-EM sample preparation and data collection 46, 47 , and data processing 44, 48, 49 .
? trouBlesHootInG Troubleshooting advice can be found in table 1. 
antIcIpateD results
Preparation of SMA co-polymer will yield ~25 g of hydrolyzed white powder that can be used to prepare SMALP membrane proteins. SMA can be added directly to resuspended membranes, or it can be added as a solution at a recommended final concentration of 2.5% (wt/vol). When SMA co-polymer is added to a membrane preparation, the cloudy solution should begin to clear, and after 2 h it will be translucent (Fig. 1b) . At that point, it can be assumed that the protein is in the SMALP. Purification of SMALP proteins using an attached affinity tag such as a six-histidine tag allows the isolation of the protein with surrounding lipids in the form of a SMALP protein. When isolating SMALPs containing membrane proteins, the use of size-exclusion chromatography as a secondary procedure after elution from IMAC resin substantially improves yield and purity. To demonstrate the SMALP method, here we describe the purification of the bacterial divisome protein ZipA from E. coli 50 . ZipA is a 36.5-kDa protein that has one transmembrane helix. ZipA as purified here contains a C-terminal six-histidine tag and a V5 epitope, which increases the total size of the protein to 39.5 kDa. ZipA was expressed and extracted from E. coli membranes using SMA co-polymer and was then bound to IMAC resin. The resin was washed with low concentrations of imidazole and eluted with buffer containing 500 mM imidazole. Fractions were analyzed by SDS-PAGE, and protein containing SMALP-ZipA was pooled, concentrated and applied to a Superdex 200 Increase column (Fig. 4a) . Pooled fractions eluted from size-exclusion chromatography were analyzed using SDS-PAGE to show the protein purity after a two-step purification approach (Fig. 4a) . Results of ZipA purification from membranes can be seen in Figure 4b . The band from SDS-PAGE was confirmed by Fourier transform -ion cyclotron resonance mass spectrometry as ZipA. The protein is seen here at 52 kDa (Fig. 4b) . This protein is known to run aberrantly on SDS-PAGE 51 , a property that is unrelated to ZipA being within a SMALP, and membranes containing ZipA show a protein band similar in size to purified SMALP protein (Fig. 4b) . SMALP-ZipA is active and able to interact with its functional partner FtsZ. A sedimentation assay for the polymerization of FtsZ in the presence or absence of SMALP-ZipA confirms biological activity, with SMALP-ZipA increasing the amount of FtsZ polymers that are found to be isolated in the pellet fraction (Fig. 4c) .
svAUC of a fraction taken from size-exclusion chromatography revealed that SMALP-ZipA was present as a single species with a sedimentation coefficient of 4.0 S. This is consistent with a molecular mass of ~70 kDa. SMA and lipid present in the SMALP contributed 30-35 kDa to the total molecular mass of the protein-SMALP particle (Fig. 4d) . However, not all fractions of purified SMALP-ZipA analyzed by AUC were shown to be monomeric. Samples of pure SMALP-ZipA analyzed from the beginning of the size-exclusion chromatography elution peak were consistent with aggregated SMALPs, dimers and tetramers. This is evidence that proteins are either (a) sampled as they exist in the membrane (i.e., together) or (b) associating with each other as demonstrated with SMALP AcrB 27 .
The CD spectroscopy spectrum of purified SMALP-ZipA showed that purified SMALP-ZipA consists of α-helices, β-sheets and unstructured regions, which is consistent with the predicted structure of ZipA. This suggests that purification of SMALP-ZipA by following solubilization and purification steps from this protocol allows the protein to retain its native secondary structure. We used a JASCO J-715 CD spectrometer to collect CD data; CD spectra were collected using a 1-mmpath-length cuvette and averaged over eight scans in the far-UV domain. We corrected the acquired spectra for the buffer signal. The protein concentration of purified SMALP-ZipA was 0.05 mg ml − 1 (Fig. 4e) . coMpetInG FInancIal Interests The authors declare no competing financial interests.
